Warszycki Dawid, Mordalski Stefan, Kristiansen Kurt, Kafel Rafał, Sylte Ingebrigt, Chilmonczyk Zdzisław, Bojarski Andrzej J
Medicinal Chemistry Department, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Medicinal Pharmacology and Toxicology, Department of Medicinal Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
PLoS One. 2013 Dec 18;8(12):e84510. doi: 10.1371/journal.pone.0084510. eCollection 2013.
This study explores a new approach to pharmacophore screening involving the use of an optimized linear combination of models instead of a single hypothesis. The implementation and evaluation of the developed methodology are performed for a complete known chemical space of 5-HT1AR ligands (3616 active compounds with K i < 100 nM) acquired from the ChEMBL database. Clusters generated from three different methods were the basis for the individual pharmacophore hypotheses, which were assembled into optimal combinations to maximize the different coefficients, namely, MCC, accuracy and recall, to measure the screening performance. Various factors that influence filtering efficiency, including clustering methods, the composition of test sets (random, the most diverse and cluster population-dependent) and hit mode (the compound must fit at least one or two models from a final combination) were investigated. This method outmatched both single hypothesis and random linear combination approaches.
本研究探索了一种新的药效团筛选方法,该方法涉及使用模型的优化线性组合而非单一假设。针对从ChEMBL数据库获取的5-HT1AR配体的完整已知化学空间(3616种活性化合物,K i < 100 nM),对所开发方法进行了实施和评估。由三种不同方法生成的聚类是各个药效团假设的基础,这些假设被组装成最优组合,以最大化不同系数,即马修斯相关系数(MCC)、准确率和召回率,来衡量筛选性能。研究了各种影响筛选效率的因素,包括聚类方法、测试集的组成(随机、最多样化和聚类群体相关)以及命中模式(化合物必须符合最终组合中的至少一个或两个模型)。该方法优于单一假设和随机线性组合方法。